Common Stock, Shares, Outstanding of IGC Pharma, Inc. from 31 Mar 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
IGC Pharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2010 to 30 Sep 2025.
  • IGC Pharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 91,959,112, a 20% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 91,959,112 +15,322,693 +20% 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 84,141,405 +8,504,986 +11% 30 Jun 2025 10-Q 14 Aug 2025 2026 Q1
Q1 2025 80,878,058 +14,186,863 +21% 31 Mar 2025 10-Q 14 Nov 2025 2026 Q2
Q4 2024 78,203,218 +14,468,779 +23% 31 Dec 2024 10-Q 14 Feb 2025 2025 Q3
Q3 2024 76,636,419 +12,929,480 +20% 30 Sep 2024 10-Q 12 Nov 2024 2025 Q2
Q2 2024 75,636,419 +22,558,983 +43% 30 Jun 2024 10-Q 07 Aug 2024 2025 Q1
Q1 2024 66,691,195 +13,613,759 +26% 31 Mar 2024 10-K 27 Jun 2025 2025 FY
Q4 2023 63,734,439 +10,657,003 +20% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q3
Q3 2023 63,706,939 +10,648,878 +20% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 53,077,436 +1,236,833 +2.4% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 53,077,436 +2,023,419 +4% 31 Mar 2023 10-K 24 Jun 2024 2024 FY
Q4 2022 53,077,436 +2,023,419 +4% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 53,058,061 +2,017,044 +4% 30 Sep 2022 10-Q 01 Nov 2022 2023 Q2
Q2 2022 51,840,603 +3,556,586 +7.4% 30 Jun 2022 10-Q 05 Aug 2022 2023 Q1
Q1 2022 51,054,017 +3,226,744 +6.7% 31 Mar 2022 10-K 07 Jul 2023 2023 FY
Q4 2021 51,054,017 +9,749,652 +24% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q3
Q3 2021 51,041,017 +9,736,652 +24% 30 Sep 2021 10-Q 29 Oct 2021 2022 Q2
Q2 2021 48,284,017 +7,087,887 +17% 30 Jun 2021 10-Q 11 Aug 2021 2022 Q1
Q1 2021 47,827,273 +8,507,157 +22% 31 Mar 2021 10-K 23 Jun 2022 2022 FY
Q4 2020 41,304,365 +1,732,958 +4.4% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 41,304,365 +1,732,958 +4.4% 30 Sep 2020 10-Q 20 Nov 2020 2021 Q2
Q2 2020 41,196,130 +1,684,723 +4.3% 30 Jun 2020 10-Q 19 Aug 2020 2021 Q1
Q1 2020 39,320,116 -181,291 -0.46% 31 Mar 2020 10-K 14 Jun 2021 2021 FY
Q4 2019 39,571,407 -15,415 -0.04% 31 Dec 2019 10-Q 10 Feb 2020 2020 Q3
Q3 2019 39,571,407 +5,323,638 +16% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q2
Q2 2019 39,511,407 +8,472,934 +27% 30 Jun 2019 10-Q 09 Aug 2019 2020 Q1
Q1 2019 39,501,407 +8,737,215 +28% 31 Mar 2019 10-K 13 Jul 2020 2020 FY
Q4 2018 39,586,822 +10,087,032 +34% 31 Dec 2018 10-Q 12 Feb 2019 2019 Q3
Q3 2018 34,247,769 +6,242,497 +22% 30 Sep 2018 10-Q 16 Oct 2018 2019 Q2
Q2 2018 31,038,473 +4,235,453 +16% 30 Jun 2018 10-Q 03 Aug 2018 2019 Q1
Q1 2018 30,764,192 +2,491,525 +8.8% 31 Mar 2018 10-K 14 Jun 2019 2019 FY
Q4 2017 29,499,790 -342,497 -1.1% 31 Dec 2017 10-Q 20 Feb 2018 2018 Q3
Q3 2017 28,005,272 +4,047,445 +17% 30 Sep 2017 10-Q 17 Nov 2017 2018 Q2
Q2 2017 26,803,020 +3,537,489 +15% 30 Jun 2017 10-Q 18 Aug 2017 2018 Q1
Q1 2017 28,272,667 +5,007,136 +22% 31 Mar 2017 10-K 21 Jun 2018 2018 FY
Q4 2016 29,842,287 +12,722,285 +74% 31 Dec 2016 10-Q 21 Feb 2017 2017 Q3
Q3 2016 23,957,827 +7,734,477 +48% 30 Sep 2016 10-Q 21 Nov 2016 2017 Q2
Q2 2016 23,265,531 +8,273,733 +55% 30 Jun 2016 10-Q 16 Aug 2016 2017 Q1
Q1 2016 23,265,531 +8,499,198 +58% 31 Mar 2016 10-K 14 Jul 2017 2017 FY
Q4 2015 17,120,002 +3,600,647 +27% 31 Dec 2015 10-Q 16 Feb 2016 2016 Q3
Q3 2015 16,223,350 +3,974,462 +32% 30 Sep 2015 10-Q 13 Nov 2015 2016 Q2
Q2 2015 14,991,798 +2,500,788 +20% 30 Jun 2015 10-Q 14 Aug 2015 2016 Q1
Q1 2015 14,766,333 +5,392,764 +58% 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q4 2014 13,519,355 +5,538,436 +69% 31 Dec 2014 10-Q 12 Feb 2015 2015 Q3
Q3 2014 12,248,888 +4,767,462 +64% 30 Sep 2014 10-Q 13 Nov 2014 2015 Q2
Q2 2014 12,491,010 +5,459,612 +78% 30 Jun 2014 10-Q 14 Aug 2014 2015 Q1
Q1 2014 9,373,569 +2,393,471 +34% 31 Mar 2014 10-K 14 Jul 2015 2015 FY
Q4 2013 7,980,919 -52,080,818 -87% 31 Dec 2013 10-Q 14 Feb 2014 2013 Q3
Q3 2013 7,481,426 -52,580,311 -88% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q2
Q2 2013 7,031,398 -53,030,339 -88% 30 Jun 2013 10-Q 16 Aug 2013 2013 Q1
Q1 2013 6,980,098 +973,925 +16% 31 Mar 2013 10-K 15 Jul 2014 2014 FY
Q4 2012 60,061,737 +12,469,894 +26% 31 Dec 2012 10-Q 13 Feb 2013 2012 Q3
Q3 2012 60,061,737 +43,969,894 +273% 30 Sep 2012 10-Q 14 Nov 2012 2012 Q2
Q2 2012 60,061,737 +43,969,894 +273% 30 Jun 2012 10-Q/A 21 Aug 2012 2012 Q1
Q1 2012 6,006,173 -8,884,008 -60% 31 Mar 2012 10-K 15 Jul 2014 2013 FY
Q4 2011 47,591,843 31 Dec 2011 10-Q 16 Feb 2012 2011 Q3
Q3 2011 16,091,843 30 Sep 2011 10-Q 18 Nov 2011 2011 Q2
Q2 2011 16,091,843 30 Jun 2011 10-Q 18 Aug 2011 2011 Q1
Q1 2011 14,890,181 +13,591,260 +1046% 31 Mar 2011 10-K 16 Jul 2012 2011 FY
Q1 2010 1,298,921 31 Mar 2010 10-K 14 Jul 2016 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.